(19)
(11) EP 3 911 415 A1

(12)

(43) Date of publication:
24.11.2021 Bulletin 2021/47

(21) Application number: 21742678.2

(22) Date of filing: 30.03.2021
(51) International Patent Classification (IPC): 
A61P 31/14(2006.01)
(86) International application number:
PCT/CA2021/050425
(87) International publication number:
WO 2021/195765 (07.10.2021 Gazette 2021/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.03.2020 US 202063001972 P
25.05.2020 US 202063029685 P
10.06.2020 CA 3083002

(71) Applicant: PULMONEM INC.
Dieppe, NB E1A 6R8 (CA)

(72) Inventors:
  • SEKHAVAT, Houfar
    Dieppe, New Brunswick E1A 6R8 (CA)
  • ASOTRA, Satish
    Dieppe, New Brunswick E1A 6R8 (CA)

(74) Representative: Loo, Chi Ching et al
Albright IP Limited County House Bayshill Road
Cheltenham, Gloucestershire GL50 3BA
Cheltenham, Gloucestershire GL50 3BA (GB)

   


(54) DAPSONE FORMULATIONS AND METHODS OF USING SAME